Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1999-1-28
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0084-5957
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
287-310
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9889995-Homocysteine,
pubmed-meshheading:9889995-Humans,
pubmed-meshheading:9889995-Kidney,
pubmed-meshheading:9889995-Kidney Failure, Chronic,
pubmed-meshheading:9889995-Methylenetetrahydrofolate Reductase (NADPH2),
pubmed-meshheading:9889995-Oxidoreductases Acting on CH-NH Group Donors
|
pubmed:year |
1998
|
pubmed:articleTitle |
Homocysteine and chronic renal failure.
|
pubmed:affiliation |
Louis Pasteur University Medical School, Strasbourg, France.
|
pubmed:publicationType |
Journal Article,
Review
|